Abstract 4613: ZMS-4426, an oral degrader of SMARCA2 shows potent anti-tumor activity, but variant selectivity against SMARCA4 across species

SMARCA4型 癌症研究 赫拉 细胞生长 化学 体外 细胞培养 癌症 生长抑制 细胞 生物 选择性 基因 表型 癌细胞 分子生物学 细胞毒性 HEK 293细胞 细胞生物学 药理学 蛋白质组
作者
Lu Liu,Fanxun Zeng,Ruonan Chen,Mengnan Hu,Yao Guo,Wenjing Li,Mei Lan,Liting Xue,Zhengtao Li,Renheng Tang
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:86 (7_Supplement): 4613-4613
标识
DOI:10.1158/1538-7445.am2026-4613
摘要

Abstract Mammalian SWI/SNF complexes always contain one of two mutually exclusive and structurally highly related ATPases: SMARCA2/BRM or SMARCA4/BRG1, as its catalytic subunit. It is reported that SMARCA4 is absent in a serial of cancers, and these SMARCA4 deficient cancer cells are highly dependent on its paralog SMARCA2 for survival. Therefore, it holds great therapeutic promise to treat SMARCA4 deficient cancers with selective SMARCA2 degraders. Here, we reported ZMS-4426, a highly selective SMARCA2 degrader. In HiBiT knock-in HeLa cells, it potently degraded SMARCA2 with a >10,000-fold selectivity over SMARCA4. The global proteome data also indicated that ZMS-4426 was highly specific in degrading the expected target proteins SMARCA2. Furthermore, ZMS-4426 demonstrated high degradation selectivity of SMARCA2 over SMARCA4 in a variety of human cancer cell lines and PBMCs of multiple species. However, in dog PBMCs, the degradation selectivity between SMARCA2 and SMARCA4 varies among individuals.Due to the high selectivity over SMARCA4, ZMS-4426 effectively inhibited the proliferation of SMARCA4 deficient cells, and inhibited the proliferation of neither SMARCA2/4-WT cells nor SMARCA2/4-DEL cells. Furthermore, the in vitro synergistic effects were observed when SMARCA4-loss NSCLC cells were treated with ZMS-4426 in combination with docetaxel.ZMS-4426 exhibited good oral availability in mice, rats, and dog. In the NSCLC NCI-H838 CDX model, ZMS-4426 effectively inhibited tumor growth, and the tumor growth inhibition (TGI) correlated well with SMARCA2 degradation in tumors. Further, the combination treatment of ZMS-4426 and nab-paclitaxel effectively suppressed tumor growth to a greater extent than either agent alone. However, ZMS-4426 was not tolerated in dog for 7-day treatment at 2 mpk. Strong degradation of SMARCA4 in lung was detected, suggesting poor in vivo degradation selectivity in dog. Further, in monkey, the treatment of ZMS-4426 for 7-day at 1.5 mpk resulted in body weight loss and deep degradation of SMARCA4 in PBMCs, indicating that in vitro degradation selectivity in monkey PBMCs did not maintained in vivo.Similar findings were also observed in rats. In a head-to-head comparison with compound A (a reference molecule from WO2025194405, Prelude Therapeutics), treatment of ZMS-4426 and compound A for 4-day at 5 mpk intravenous injection in rats both induced complete degradation of SMARCA4 at 24 hours post-dose, indicating that neither compound preserved its selectivity profile in vivo.In conclusion, our potent and selective SMARCA2 degrader, ZMS-4426 induces strong synthetic lethality in SMARCA4 deficient cells both in vitro and in vivo. However, more studies are needed to elucidate discrepancy in degradation selectivity between in vitro and in vivo results. Citation Format: Lu Liu, Fanxun Zeng, Ruonan Chen, Mengnan Hu, Yao Guo, Wenjing Li, Mei Lan, Liting Xue, Zhengtao Li, Renheng Tang, . ZMS-4426, an oral degrader of SMARCA2 shows potent anti-tumor activity, but variant selectivity against SMARCA4 across species [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 4613.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
华仔的应助被罗鑫采纳,获得10
刚刚
lin发布了新的文献求助10
1秒前
1秒前
2秒前
菠菜发布了新的文献求助200
2秒前
mbl2006完成签到 ,获得积分10
2秒前
3秒前
慕青的应助被白白采纳,获得10
3秒前
华安完成签到,获得积分10
3秒前
LT发布了新的文献求助10
3秒前
科研通AI6.4的应助被抗体小王采纳,获得10
3秒前
chenyiyi发布了新的文献求助20
4秒前
顾矜的应助被湛蓝的天空采纳,获得30
4秒前
orixero的应助被成就的沛菡采纳,获得10
5秒前
桃里里完成签到,获得积分10
5秒前
小易完成签到,获得积分10
6秒前
嘴遁老铁叽完成签到,获得积分10
6秒前
沉默红牛完成签到,获得积分10
6秒前
ming完成签到 ,获得积分10
6秒前
6秒前
7秒前
淼淼发布了新的文献求助10
7秒前
坦率的山菡完成签到,获得积分10
7秒前
morris发布了新的文献求助10
7秒前
孙佳乐完成签到 ,获得积分10
7秒前
7秒前
嗒嗒完成签到,获得积分10
8秒前
8秒前
隐形曼青的应助被QQ采纳,获得10
8秒前
积极妙菡关注了科研通微信公众号
9秒前
Eason完成签到,获得积分10
9秒前
9秒前
八森木完成签到,获得积分0
10秒前
打打的应助被Waboss采纳,获得10
10秒前
sunnymoon发布了新的文献求助10
11秒前
赵晋杰完成签到,获得积分20
11秒前
11秒前
Yyy发布了新的文献求助10
11秒前
sunnymoon发布了新的文献求助10
11秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8161320
求助须知:如何正确求助?哪些是违规求助? 9556074
关于积分的说明 21732157
捐赠科研通 7751456
什么是DOI,文献DOI怎么找? 3427537
关于科研通互助平台的介绍 2552583
邀请新用户注册赠送积分活动 2471992